Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

22 trials with published results (13%)

Research Maturity

89 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.0%

12 terminated out of 172 trials

Success Rate

88.1%

+1.6% vs benchmark

Late-Stage Pipeline

5%

8 trials in Phase 3/4

Results Transparency

25%

22 of 89 completed with results

Key Signals

22 with results88% success12 terminated

Data Visualizations

Phase Distribution

112Total
Not Applicable (71)
Early P 1 (1)
P 1 (13)
P 2 (19)
P 3 (1)
P 4 (7)

Trial Status

Completed89
Recruiting27
Unknown26
Terminated12
Active Not Recruiting8
Not Yet Recruiting4

Trial Success Rate

88.1%

Benchmark: 86.6%

Based on 89 completed trials

Clinical Trials (172)

Showing 20 of 20 trials
NCT03539692RecruitingPrimary

Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site

NCT02504853RecruitingPrimary

Natural History and Genetics of Food Allergy and Related Conditions

NCT07321522Not ApplicableRecruitingPrimary

Early Introduction and Sustained Ingestion (EISI) Using Two Educational Opportunities in Infants

NCT06369467Phase 1Active Not RecruitingPrimary

Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy

NCT06631677UnknownPrimary

Expanded Access of Dupilumab in Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Previously Treated With Linvoseltamab

NCT03679676Phase 2Completed

Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)

NCT04798079Active Not Recruiting

Systems Biology of Early Atopy

NCT06467994Phase 2Recruiting

Boiled Tree Nut for Oral Immunotherapy in Food-allergic Children

NCT07212530Not ApplicableRecruiting

EmoTIChealth: Promoting Adolescent Health Through a Serious Game.

NCT06380673Not ApplicableRecruitingPrimary

Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy

NCT06273605Not ApplicableCompletedPrimary

The Egg Up Trial - Testing a New Treatment Pathway for Infants With Newly Diagnosed Egg Allergy

NCT07210320Phase 1CompletedPrimary

PK/PD Study of IN-001 Sublingual Spray in Healthy Adults

NCT03181009Phase 2CompletedPrimary

Multi OIT to Test Immune Markers After Minimum Maintenance Dose

NCT06529913Not ApplicableRecruiting

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

NCT06943534Phase 2Recruiting

Omalizumab Weight-Based Dosing Efficacy Trial

NCT03265262Not ApplicableCompletedPrimary

The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy

NCT05678959Phase 3TerminatedPrimary

Long-term Extension Study of Ligelizumab in Food Allergy

NCT06872996Not ApplicableRecruitingPrimary

Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results

NCT02112734Phase 4Active Not RecruitingPrimary

Can Vitamin D Supplementation in the First Year of Life Prevent Food Allergy in Infants? The VITALITY Trial: Parts 1&2

NCT06554691Active Not RecruitingPrimary

Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets

Scroll to load more

Research Network

Activity Timeline